Circulating miR-155 in whole blood of patients with breast cancer
10.3760/cma.j.issn.1674-6090.2012.02.002
- VernacularTitle:全血中miR-155与乳腺癌的关系研究
- Author:
Xueying ZHANG
;
Linlin ZHEN
;
Xuedong HAN
;
Jianhua SHI
;
Wei SONG
;
Xiaolan QIU
- Publication Type:Journal Article
- Keywords:
Breast cancer;
miRNA;
Whole blood;
Real-time qPCR
- From:
Journal of Endocrine Surgery
2012;06(2):77-80
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo investigate the expression of miR-155 in whole blood of patients with breast cancer and explore the possibility of miR-155 in whole blood as a marker of beast cancer. Methods65 cases (breast cancer:47 cases, non-breast cancer:18 cases) in Thyroid and Breast Surgery Department of No.1 People's Hospital of Huai'an from Dec 2010 to Apr 2011 were enrolled according to the selected criteria.Two milliliters anticoagulant blood were sampled to isolate total RNA.The expression level of miR-155 in whole blood was measured by real-time quantitative polymerase chain reaction (real-time qPCR)analysis.The relationship between the expression level of miR-155 in whole blood and the clinical pathological fearutres was analyzed.ResultsThe expression level of miR-155 in breast cancer patients was up-regulated compared with that in non-breast cancer patients(P ＜ 0.05).The expression level of miR-155 in patients with positive lymph nodes was up-regulated compared with that in patients with negative lymph nodes( P ＜ 0.05).The expression level of miR-155 in stage Ⅲ breast cancer was up-regulated compared with that in stage Ⅰ & Ⅱ breast cancer( P ＜ 0.05 ).The expression level of miR-155 in patients with positive ER and PR was down-regulated compared with that in patients with negative ER and PR breast cancer.Conclusion The study demonstrates that the expression of miR-155 in whole blood is related to clinical pathological features of patients with breast cancer and can be used as a potential marker of breast cancer.
